The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Shanghai Henlius Biotech
A phase 2 study of HLX208, a BRAFV600E inhibitor, in adult patients with Langerhans cell histiocytosis and/or Erdheim-Chester disease harboring BRAFV600E mutation.
 
Xin-xin Cao
No Relationships to Disclose
 
Yu Wu
No Relationships to Disclose
 
Peng Liu
No Relationships to Disclose
 
Tianling Ding
No Relationships to Disclose
 
Hongying Ye
No Relationships to Disclose
 
Zhen Cai
No Relationships to Disclose
 
Yu Zhang
No Relationships to Disclose
 
Chen Hu
Employment - Shanghai Henlius Biotech
 
Xiaoli Hou
Employment - Shanghai Henlius Biotech
 
Guiyu Yang
Employment - Shanghai Henlius Biotech
 
Qingyu Wang
No Relationships to Disclose
 
Jun Zhu
Employment - Shanghai Henlius Biotech
 
Jian Li
No Relationships to Disclose